nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Hepatic failure—Temozolomide—melanoma	0.00249	0.00363	CcSEcCtD
Cyproterone acetate—Hot flush—Temozolomide—melanoma	0.00239	0.00349	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Temozolomide—melanoma	0.00237	0.00346	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Temozolomide—melanoma	0.00237	0.00346	CcSEcCtD
Cyproterone acetate—Cough—Vemurafenib—melanoma	0.0023	0.00335	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Dactinomycin—melanoma	0.00229	0.00333	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00223	0.00325	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00223	0.00325	CcSEcCtD
Cyproterone acetate—Affect lability—Temozolomide—melanoma	0.00221	0.00321	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Carmustine—melanoma	0.00214	0.00312	CcSEcCtD
Cyproterone acetate—Mood swings—Temozolomide—melanoma	0.00212	0.00309	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Vemurafenib—melanoma	0.00211	0.00308	CcSEcCtD
Cyproterone acetate—Skin disorder—Vemurafenib—melanoma	0.00209	0.00305	CcSEcCtD
Cyproterone acetate—Weight decreased—Bleomycin—melanoma	0.00208	0.00302	CcSEcCtD
Cyproterone acetate—Pulmonary embolism—Docetaxel—melanoma	0.00205	0.00299	CcSEcCtD
Cyproterone acetate—Muscular weakness—Carmustine—melanoma	0.00204	0.00298	CcSEcCtD
Cyproterone acetate—Injection site reaction—Docetaxel—melanoma	0.00204	0.00297	CcSEcCtD
Cyproterone acetate—Breast disorder—Temozolomide—melanoma	0.00202	0.00295	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Bleomycin—melanoma	0.00202	0.00294	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00202	0.00294	CcSEcCtD
Cyproterone acetate—Hypotension—Vemurafenib—melanoma	0.00201	0.00293	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Bleomycin—melanoma	0.00201	0.00292	CcSEcCtD
Cyproterone acetate—Muscular weakness—Temozolomide—melanoma	0.00198	0.00288	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Temozolomide—melanoma	0.00198	0.00288	CcSEcCtD
Cyproterone acetate—Haematuria—Bleomycin—melanoma	0.00195	0.00284	CcSEcCtD
Cyproterone acetate—Fluid retention—Docetaxel—melanoma	0.00195	0.00284	CcSEcCtD
Cyproterone acetate—Sweating increased—Temozolomide—melanoma	0.00189	0.00275	CcSEcCtD
Cyproterone acetate—Decreased appetite—Vemurafenib—melanoma	0.00187	0.00273	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Vemurafenib—melanoma	0.00186	0.00271	CcSEcCtD
Cyproterone acetate—Fatigue—Vemurafenib—melanoma	0.00186	0.0027	CcSEcCtD
Cyproterone acetate—Neoplasm—Docetaxel—melanoma	0.00186	0.0027	CcSEcCtD
Cyproterone acetate—Haemoglobin—Bleomycin—melanoma	0.00185	0.00269	CcSEcCtD
Cyproterone acetate—Constipation—Vemurafenib—melanoma	0.00184	0.00268	CcSEcCtD
Cyproterone acetate—Haemorrhage—Bleomycin—melanoma	0.00184	0.00268	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Carmustine—melanoma	0.00181	0.00263	CcSEcCtD
Cyproterone acetate—Pollakiuria—Temozolomide—melanoma	0.00179	0.0026	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Temozolomide—melanoma	0.00178	0.0026	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Temozolomide—melanoma	0.00177	0.00257	CcSEcCtD
Cyproterone acetate—Weight increased—Temozolomide—melanoma	0.00176	0.00257	CcSEcCtD
Cyproterone acetate—Renal failure—Carmustine—melanoma	0.00176	0.00256	CcSEcCtD
Cyproterone acetate—Weight decreased—Temozolomide—melanoma	0.00175	0.00255	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Temozolomide—melanoma	0.00175	0.00254	CcSEcCtD
Cyproterone acetate—Phlebitis—Docetaxel—melanoma	0.00173	0.00252	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Docetaxel—melanoma	0.00172	0.00251	CcSEcCtD
Cyproterone acetate—Hepatitis—Dactinomycin—melanoma	0.00171	0.0025	CcSEcCtD
Cyproterone acetate—Body temperature increased—Vemurafenib—melanoma	0.0017	0.00248	CcSEcCtD
Cyproterone acetate—Hepatic failure—Docetaxel—melanoma	0.00166	0.00241	CcSEcCtD
Cyproterone acetate—Chills—Bleomycin—melanoma	0.00165	0.0024	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Temozolomide—melanoma	0.00163	0.00238	CcSEcCtD
Cyproterone acetate—Alopecia—Bleomycin—melanoma	0.00162	0.00236	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Dactinomycin—melanoma	0.00162	0.00236	CcSEcCtD
Cyproterone acetate—Haemoglobin—Carmustine—melanoma	0.00161	0.00235	CcSEcCtD
Cyproterone acetate—Haemorrhage—Carmustine—melanoma	0.0016	0.00234	CcSEcCtD
Cyproterone acetate—Hot flush—Docetaxel—melanoma	0.00159	0.00232	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Vemurafenib—melanoma	0.00159	0.00231	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Docetaxel—melanoma	0.00158	0.0023	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Carmustine—melanoma	0.00158	0.00229	CcSEcCtD
Cyproterone acetate—Haemoglobin—Temozolomide—melanoma	0.00156	0.00227	CcSEcCtD
Cyproterone acetate—Haemorrhage—Temozolomide—melanoma	0.00155	0.00226	CcSEcCtD
Cyproterone acetate—Hepatitis—Temozolomide—melanoma	0.00155	0.00226	CcSEcCtD
Cyproterone acetate—Asthenia—Vemurafenib—melanoma	0.00155	0.00225	CcSEcCtD
Cyproterone acetate—Visual impairment—Carmustine—melanoma	0.00155	0.00225	CcSEcCtD
Cyproterone acetate—Chills—Dactinomycin—melanoma	0.00154	0.00224	CcSEcCtD
Cyproterone acetate—Cardiac failure—Docetaxel—melanoma	0.00153	0.00222	CcSEcCtD
Cyproterone acetate—Pruritus—Vemurafenib—melanoma	0.00152	0.00222	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Temozolomide—melanoma	0.00152	0.00222	CcSEcCtD
Cyproterone acetate—Alopecia—Dactinomycin—melanoma	0.00151	0.0022	CcSEcCtD
Cyproterone acetate—Eye disorder—Carmustine—melanoma	0.0015	0.00218	CcSEcCtD
Cyproterone acetate—Visual impairment—Temozolomide—melanoma	0.00149	0.00217	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Bleomycin—melanoma	0.00148	0.00216	CcSEcCtD
Cyproterone acetate—Anaemia—Bleomycin—melanoma	0.00148	0.00215	CcSEcCtD
Cyproterone acetate—Diarrhoea—Vemurafenib—melanoma	0.00147	0.00215	CcSEcCtD
Cyproterone acetate—Migraine—Docetaxel—melanoma	0.00147	0.00214	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Temozolomide—melanoma	0.00147	0.00213	CcSEcCtD
Cyproterone acetate—Eye disorder—Temozolomide—melanoma	0.00145	0.00211	CcSEcCtD
Cyproterone acetate—Malaise—Bleomycin—melanoma	0.00144	0.0021	CcSEcCtD
Cyproterone acetate—Leukopenia—Bleomycin—melanoma	0.00143	0.00208	CcSEcCtD
Cyproterone acetate—Dizziness—Vemurafenib—melanoma	0.00142	0.00207	CcSEcCtD
Cyproterone acetate—Alopecia—Carmustine—melanoma	0.00142	0.00206	CcSEcCtD
Cyproterone acetate—Angiopathy—Temozolomide—melanoma	0.00141	0.00205	CcSEcCtD
Cyproterone acetate—Mental disorder—Carmustine—melanoma	0.00141	0.00205	CcSEcCtD
Cyproterone acetate—Immune system disorder—Temozolomide—melanoma	0.0014	0.00204	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Temozolomide—melanoma	0.0014	0.00203	CcSEcCtD
Cyproterone acetate—Malnutrition—Carmustine—melanoma	0.0014	0.00203	CcSEcCtD
Cyproterone acetate—Cough—Bleomycin—melanoma	0.0014	0.00203	CcSEcCtD
Cyproterone acetate—Chills—Temozolomide—melanoma	0.00139	0.00203	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Dactinomycin—melanoma	0.00138	0.00202	CcSEcCtD
Cyproterone acetate—Anaemia—Dactinomycin—melanoma	0.00138	0.00201	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Docetaxel—melanoma	0.00138	0.002	CcSEcCtD
Cyproterone acetate—Vomiting—Vemurafenib—melanoma	0.00137	0.00199	CcSEcCtD
Cyproterone acetate—Alopecia—Temozolomide—melanoma	0.00137	0.00199	CcSEcCtD
Cyproterone acetate—Rash—Vemurafenib—melanoma	0.00136	0.00198	CcSEcCtD
Cyproterone acetate—Mental disorder—Temozolomide—melanoma	0.00136	0.00198	CcSEcCtD
Cyproterone acetate—Dermatitis—Vemurafenib—melanoma	0.00136	0.00198	CcSEcCtD
Cyproterone acetate—Headache—Vemurafenib—melanoma	0.00135	0.00197	CcSEcCtD
Cyproterone acetate—Malnutrition—Temozolomide—melanoma	0.00135	0.00196	CcSEcCtD
Cyproterone acetate—Breast disorder—Docetaxel—melanoma	0.00135	0.00196	CcSEcCtD
Cyproterone acetate—Discomfort—Bleomycin—melanoma	0.00135	0.00196	CcSEcCtD
Cyproterone acetate—Malaise—Dactinomycin—melanoma	0.00135	0.00196	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00134	0.00195	CcSEcCtD
Cyproterone acetate—Leukopenia—Dactinomycin—melanoma	0.00134	0.00194	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Docetaxel—melanoma	0.00131	0.00191	CcSEcCtD
Cyproterone acetate—Oedema—Bleomycin—melanoma	0.00131	0.0019	CcSEcCtD
Cyproterone acetate—Anaemia—Carmustine—melanoma	0.00129	0.00188	CcSEcCtD
Cyproterone acetate—Agitation—Carmustine—melanoma	0.00128	0.00187	CcSEcCtD
Cyproterone acetate—Nausea—Vemurafenib—melanoma	0.00128	0.00186	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Bleomycin—melanoma	0.00128	0.00186	CcSEcCtD
Cyproterone acetate—Discomfort—Dactinomycin—melanoma	0.00125	0.00183	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Temozolomide—melanoma	0.00125	0.00182	CcSEcCtD
Cyproterone acetate—Leukopenia—Carmustine—melanoma	0.00125	0.00182	CcSEcCtD
Cyproterone acetate—Anaemia—Temozolomide—melanoma	0.00125	0.00182	CcSEcCtD
Cyproterone acetate—Anorexia—Bleomycin—melanoma	0.00124	0.00181	CcSEcCtD
Cyproterone acetate—Agitation—Temozolomide—melanoma	0.00124	0.00181	CcSEcCtD
Cyproterone acetate—Hypotension—Bleomycin—melanoma	0.00122	0.00178	CcSEcCtD
Cyproterone acetate—Oedema—Dactinomycin—melanoma	0.00122	0.00177	CcSEcCtD
Cyproterone acetate—Malaise—Temozolomide—melanoma	0.00122	0.00177	CcSEcCtD
Cyproterone acetate—Leukopenia—Temozolomide—melanoma	0.00121	0.00176	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Dactinomycin—melanoma	0.00119	0.00174	CcSEcCtD
Cyproterone acetate—Cough—Temozolomide—melanoma	0.00118	0.00171	CcSEcCtD
Cyproterone acetate—Weight increased—Docetaxel—melanoma	0.00117	0.00171	CcSEcCtD
Cyproterone acetate—Weight decreased—Docetaxel—melanoma	0.00116	0.0017	CcSEcCtD
Cyproterone acetate—Dyspnoea—Bleomycin—melanoma	0.00116	0.00169	CcSEcCtD
Cyproterone acetate—Anorexia—Dactinomycin—melanoma	0.00116	0.00169	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00114	0.00166	CcSEcCtD
Cyproterone acetate—Oedema—Carmustine—melanoma	0.00114	0.00166	CcSEcCtD
Cyproterone acetate—Discomfort—Temozolomide—melanoma	0.00113	0.00165	CcSEcCtD
Cyproterone acetate—Decreased appetite—Bleomycin—melanoma	0.00113	0.00165	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Docetaxel—melanoma	0.00113	0.00165	CcSEcCtD
Cyproterone acetate—Renal failure—Docetaxel—melanoma	0.00113	0.00164	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Docetaxel—melanoma	0.00113	0.00164	CcSEcCtD
Cyproterone acetate—Jaundice—Docetaxel—melanoma	0.00112	0.00163	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Carmustine—melanoma	0.00112	0.00162	CcSEcCtD
Cyproterone acetate—Tachycardia—Carmustine—melanoma	0.00111	0.00162	CcSEcCtD
Cyproterone acetate—Oedema—Temozolomide—melanoma	0.0011	0.0016	CcSEcCtD
Cyproterone acetate—Anorexia—Carmustine—melanoma	0.00109	0.00158	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Docetaxel—melanoma	0.00109	0.00158	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Temozolomide—melanoma	0.00108	0.00157	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Temozolomide—melanoma	0.00108	0.00157	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Bleomycin—melanoma	0.00108	0.00157	CcSEcCtD
Cyproterone acetate—Skin disorder—Temozolomide—melanoma	0.00107	0.00156	CcSEcCtD
Cyproterone acetate—Hypotension—Carmustine—melanoma	0.00106	0.00155	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Temozolomide—melanoma	0.00106	0.00155	CcSEcCtD
Cyproterone acetate—Decreased appetite—Dactinomycin—melanoma	0.00106	0.00154	CcSEcCtD
Cyproterone acetate—Fatigue—Dactinomycin—melanoma	0.00105	0.00153	CcSEcCtD
Cyproterone acetate—Anorexia—Temozolomide—melanoma	0.00105	0.00153	CcSEcCtD
Cyproterone acetate—Urticaria—Bleomycin—melanoma	0.00104	0.00151	CcSEcCtD
Cyproterone acetate—Haemoglobin—Docetaxel—melanoma	0.00104	0.00151	CcSEcCtD
Cyproterone acetate—Body temperature increased—Bleomycin—melanoma	0.00103	0.0015	CcSEcCtD
Cyproterone acetate—Hepatitis—Docetaxel—melanoma	0.00103	0.0015	CcSEcCtD
Cyproterone acetate—Haemorrhage—Docetaxel—melanoma	0.00103	0.0015	CcSEcCtD
Cyproterone acetate—Dyspnoea—Carmustine—melanoma	0.00102	0.00148	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Docetaxel—melanoma	0.00101	0.00147	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Dactinomycin—melanoma	0.001	0.00146	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Dactinomycin—melanoma	0.000995	0.00145	CcSEcCtD
Cyproterone acetate—Visual impairment—Docetaxel—melanoma	0.000993	0.00145	CcSEcCtD
Cyproterone acetate—Decreased appetite—Carmustine—melanoma	0.00099	0.00144	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Carmustine—melanoma	0.000984	0.00143	CcSEcCtD
Cyproterone acetate—Dyspnoea—Temozolomide—melanoma	0.000982	0.00143	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Docetaxel—melanoma	0.000975	0.00142	CcSEcCtD
Cyproterone acetate—Constipation—Carmustine—melanoma	0.000974	0.00142	CcSEcCtD
Cyproterone acetate—Dyspepsia—Temozolomide—melanoma	0.000969	0.00141	CcSEcCtD
Cyproterone acetate—Eye disorder—Docetaxel—melanoma	0.000963	0.0014	CcSEcCtD
Cyproterone acetate—Abdominal pain—Dactinomycin—melanoma	0.000962	0.0014	CcSEcCtD
Cyproterone acetate—Body temperature increased—Dactinomycin—melanoma	0.000962	0.0014	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Bleomycin—melanoma	0.000962	0.0014	CcSEcCtD
Cyproterone acetate—Decreased appetite—Temozolomide—melanoma	0.000957	0.00139	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Temozolomide—melanoma	0.000951	0.00138	CcSEcCtD
Cyproterone acetate—Fatigue—Temozolomide—melanoma	0.000949	0.00138	CcSEcCtD
Cyproterone acetate—Constipation—Temozolomide—melanoma	0.000942	0.00137	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Carmustine—melanoma	0.000939	0.00137	CcSEcCtD
Cyproterone acetate—Asthenia—Bleomycin—melanoma	0.000937	0.00136	CcSEcCtD
Cyproterone acetate—Angiopathy—Docetaxel—melanoma	0.000935	0.00136	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Carmustine—melanoma	0.000932	0.00136	CcSEcCtD
Cyproterone acetate—Immune system disorder—Docetaxel—melanoma	0.000931	0.00136	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Docetaxel—melanoma	0.000929	0.00135	CcSEcCtD
Cyproterone acetate—Chills—Docetaxel—melanoma	0.000925	0.00135	CcSEcCtD
Cyproterone acetate—Pruritus—Bleomycin—melanoma	0.000924	0.00134	CcSEcCtD
Cyproterone acetate—Alopecia—Docetaxel—melanoma	0.000911	0.00133	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Temozolomide—melanoma	0.000907	0.00132	CcSEcCtD
Cyproterone acetate—Mental disorder—Docetaxel—melanoma	0.000903	0.00131	CcSEcCtD
Cyproterone acetate—Abdominal pain—Carmustine—melanoma	0.000901	0.00131	CcSEcCtD
Cyproterone acetate—Body temperature increased—Carmustine—melanoma	0.000901	0.00131	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Temozolomide—melanoma	0.0009	0.00131	CcSEcCtD
Cyproterone acetate—Malnutrition—Docetaxel—melanoma	0.000897	0.00131	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Dactinomycin—melanoma	0.000897	0.00131	CcSEcCtD
Cyproterone acetate—Urticaria—Temozolomide—melanoma	0.000875	0.00127	CcSEcCtD
Cyproterone acetate—Asthenia—Dactinomycin—melanoma	0.000873	0.00127	CcSEcCtD
Cyproterone acetate—Body temperature increased—Temozolomide—melanoma	0.00087	0.00127	CcSEcCtD
Cyproterone acetate—Abdominal pain—Temozolomide—melanoma	0.00087	0.00127	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Carmustine—melanoma	0.000839	0.00122	CcSEcCtD
Cyproterone acetate—Diarrhoea—Dactinomycin—melanoma	0.000833	0.00121	CcSEcCtD
Cyproterone acetate—Vomiting—Bleomycin—melanoma	0.00083	0.00121	CcSEcCtD
Cyproterone acetate—Anaemia—Docetaxel—melanoma	0.000829	0.00121	CcSEcCtD
Cyproterone acetate—Rash—Bleomycin—melanoma	0.000823	0.0012	CcSEcCtD
Cyproterone acetate—Dermatitis—Bleomycin—melanoma	0.000822	0.0012	CcSEcCtD
Cyproterone acetate—Asthenia—Carmustine—melanoma	0.000817	0.00119	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Temozolomide—melanoma	0.000811	0.00118	CcSEcCtD
Cyproterone acetate—Syncope—Docetaxel—melanoma	0.000805	0.00117	CcSEcCtD
Cyproterone acetate—Leukopenia—Docetaxel—melanoma	0.000803	0.00117	CcSEcCtD
Cyproterone acetate—Asthenia—Temozolomide—melanoma	0.00079	0.00115	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Docetaxel—melanoma	0.000789	0.00115	CcSEcCtD
Cyproterone acetate—Cough—Docetaxel—melanoma	0.000783	0.00114	CcSEcCtD
Cyproterone acetate—Diarrhoea—Carmustine—melanoma	0.00078	0.00114	CcSEcCtD
Cyproterone acetate—Pruritus—Temozolomide—melanoma	0.000779	0.00113	CcSEcCtD
Cyproterone acetate—Nausea—Bleomycin—melanoma	0.000775	0.00113	CcSEcCtD
Cyproterone acetate—Vomiting—Dactinomycin—melanoma	0.000774	0.00113	CcSEcCtD
Cyproterone acetate—Rash—Dactinomycin—melanoma	0.000768	0.00112	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000759	0.0011	CcSEcCtD
Cyproterone acetate—Dizziness—Carmustine—melanoma	0.000753	0.0011	CcSEcCtD
Cyproterone acetate—Diarrhoea—Temozolomide—melanoma	0.000753	0.0011	CcSEcCtD
Cyproterone acetate—Oedema—Docetaxel—melanoma	0.000732	0.00107	CcSEcCtD
Cyproterone acetate—Dizziness—Temozolomide—melanoma	0.000728	0.00106	CcSEcCtD
Cyproterone acetate—Vomiting—Carmustine—melanoma	0.000724	0.00105	CcSEcCtD
Cyproterone acetate—Nausea—Dactinomycin—melanoma	0.000723	0.00105	CcSEcCtD
Cyproterone acetate—Shock—Docetaxel—melanoma	0.00072	0.00105	CcSEcCtD
Cyproterone acetate—Rash—Carmustine—melanoma	0.000718	0.00105	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Docetaxel—melanoma	0.000718	0.00105	CcSEcCtD
Cyproterone acetate—Dermatitis—Carmustine—melanoma	0.000718	0.00105	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Docetaxel—melanoma	0.000717	0.00104	CcSEcCtD
Cyproterone acetate—Tachycardia—Docetaxel—melanoma	0.000715	0.00104	CcSEcCtD
Cyproterone acetate—Headache—Carmustine—melanoma	0.000714	0.00104	CcSEcCtD
Cyproterone acetate—Skin disorder—Docetaxel—melanoma	0.000711	0.00104	CcSEcCtD
Cyproterone acetate—Vomiting—Temozolomide—melanoma	0.0007	0.00102	CcSEcCtD
Cyproterone acetate—Anorexia—Docetaxel—melanoma	0.000698	0.00102	CcSEcCtD
Cyproterone acetate—Rash—Temozolomide—melanoma	0.000694	0.00101	CcSEcCtD
Cyproterone acetate—Dermatitis—Temozolomide—melanoma	0.000694	0.00101	CcSEcCtD
Cyproterone acetate—Headache—Temozolomide—melanoma	0.00069	0.001	CcSEcCtD
Cyproterone acetate—Hypotension—Docetaxel—melanoma	0.000684	0.000996	CcSEcCtD
Cyproterone acetate—Nausea—Carmustine—melanoma	0.000677	0.000986	CcSEcCtD
Cyproterone acetate—Nausea—Temozolomide—melanoma	0.000654	0.000952	CcSEcCtD
Cyproterone acetate—Dyspnoea—Docetaxel—melanoma	0.000653	0.000951	CcSEcCtD
Cyproterone acetate—Dyspepsia—Docetaxel—melanoma	0.000645	0.000939	CcSEcCtD
Cyproterone acetate—Decreased appetite—Docetaxel—melanoma	0.000637	0.000927	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Docetaxel—melanoma	0.000632	0.000921	CcSEcCtD
Cyproterone acetate—Fatigue—Docetaxel—melanoma	0.000631	0.000919	CcSEcCtD
Cyproterone acetate—Constipation—Docetaxel—melanoma	0.000626	0.000912	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Docetaxel—melanoma	0.000603	0.000879	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Docetaxel—melanoma	0.000599	0.000872	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—RAC1—melanoma	0.000584	0.00186	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.00058	0.00185	CbGpPWpGaD
Cyproterone acetate—Abdominal pain—Docetaxel—melanoma	0.000579	0.000843	CcSEcCtD
Cyproterone acetate—Body temperature increased—Docetaxel—melanoma	0.000579	0.000843	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.000567	0.00181	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MMP1—melanoma	0.000565	0.0018	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—melanoma	0.000562	0.00179	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN2A—melanoma	0.000562	0.00179	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—melanoma	0.000557	0.00178	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDK2—melanoma	0.000554	0.00177	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—E2F1—melanoma	0.000553	0.00176	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—E2F1—melanoma	0.00055	0.00175	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IFNG—melanoma	0.000548	0.00175	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CLNS1A—melanoma	0.000546	0.00174	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—melanoma	0.000546	0.00174	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000545	0.00174	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.000544	0.00174	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Docetaxel—melanoma	0.000539	0.000786	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	0.000539	0.00172	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000532	0.0017	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000527	0.00168	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ATM—melanoma	0.000526	0.00168	CbGpPWpGaD
Cyproterone acetate—Asthenia—Docetaxel—melanoma	0.000525	0.000765	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDK4—melanoma	0.000524	0.00167	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000522	0.00167	CbGpPWpGaD
Cyproterone acetate—Pruritus—Docetaxel—melanoma	0.000518	0.000754	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CCND1—melanoma	0.000516	0.00165	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.000512	0.00163	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CTNNB1—melanoma	0.000511	0.00163	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CXCL8—melanoma	0.000509	0.00163	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—FAS—melanoma	0.000509	0.00163	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—RAC1—melanoma	0.000502	0.0016	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.000502	0.0016	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Docetaxel—melanoma	0.000501	0.00073	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CDKN1A—melanoma	0.000499	0.00159	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PTEN—melanoma	0.000498	0.00159	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN1B—melanoma	0.000498	0.00159	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NPPA—melanoma	0.000493	0.00157	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.000493	0.00157	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL10—melanoma	0.000491	0.00157	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000487	0.00156	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL2—melanoma	0.000487	0.00155	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—melanoma	0.000486	0.00155	CbGpPWpGaD
Cyproterone acetate—Dizziness—Docetaxel—melanoma	0.000484	0.000705	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000484	0.00154	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—melanoma	0.000483	0.00154	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—CTNNB1—melanoma	0.000481	0.00154	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—melanoma	0.00048	0.00153	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—HIF1A—melanoma	0.000479	0.00153	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SKI—melanoma	0.000478	0.00153	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDK2—melanoma	0.000477	0.00152	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCND1—melanoma	0.000475	0.00152	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CTNNB1—melanoma	0.00047	0.0015	CbGpPWpGaD
Cyproterone acetate—Vomiting—Docetaxel—melanoma	0.000466	0.000678	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BRAF—melanoma	0.000463	0.00148	CbGpPWpGaD
Cyproterone acetate—Rash—Docetaxel—melanoma	0.000462	0.000672	CcSEcCtD
Cyproterone acetate—Dermatitis—Docetaxel—melanoma	0.000461	0.000672	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—melanoma	0.000461	0.00147	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.000459	0.00147	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP8—melanoma	0.000459	0.00147	CbGpPWpGaD
Cyproterone acetate—Headache—Docetaxel—melanoma	0.000459	0.000668	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PTEN—melanoma	0.000458	0.00146	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000456	0.00146	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—RB1—melanoma	0.000455	0.00145	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CDH1—melanoma	0.000454	0.00145	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ATM—melanoma	0.000453	0.00144	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—melanoma	0.000451	0.00144	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—melanoma	0.000451	0.00144	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—melanoma	0.000449	0.00143	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.000447	0.00143	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—STAT3—melanoma	0.000446	0.00142	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.000436	0.00139	CbGpPWpGaD
Cyproterone acetate—Nausea—Docetaxel—melanoma	0.000435	0.000633	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.000434	0.00139	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACER3—melanoma	0.000429	0.00137	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—melanoma	0.000429	0.00137	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HIF1A—melanoma	0.000414	0.00132	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	0.000409	0.0013	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000409	0.0013	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—melanoma	0.000407	0.0013	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EGFR—melanoma	0.000405	0.00129	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—melanoma	0.000405	0.00129	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.000404	0.00129	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—melanoma	0.000402	0.00128	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—melanoma	0.000399	0.00127	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP8—melanoma	0.000395	0.00126	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BCL2—melanoma	0.000394	0.00126	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—UGT2B10—melanoma	0.000393	0.00125	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—RB1—melanoma	0.000392	0.00125	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—melanoma	0.00039	0.00125	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—RB1—melanoma	0.00039	0.00124	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—melanoma	0.000389	0.00124	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MDM2—melanoma	0.000388	0.00124	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000388	0.00124	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IGF1—melanoma	0.000386	0.00123	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	0.000383	0.00122	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—melanoma	0.000381	0.00122	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000381	0.00121	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NPPA—melanoma	0.000374	0.00119	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000374	0.00119	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HS3ST5—melanoma	0.000365	0.00117	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.000362	0.00115	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000354	0.00113	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP3—melanoma	0.000347	0.00111	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—melanoma	0.000345	0.0011	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000344	0.0011	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—melanoma	0.000339	0.00108	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	0.000339	0.00108	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CASP3—melanoma	0.000339	0.00108	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CCND1—melanoma	0.000338	0.00108	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—melanoma	0.000335	0.00107	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—melanoma	0.000334	0.00107	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—melanoma	0.000328	0.00105	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000327	0.00104	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PTEN—melanoma	0.000326	0.00104	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000326	0.00104	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—NFKB1—melanoma	0.000325	0.00104	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000322	0.00103	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000317	0.00101	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000317	0.00101	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—melanoma	0.000313	0.000998	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.00031	0.00099	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.00031	0.000988	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPS3—melanoma	0.000308	0.000984	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SKI—melanoma	0.000303	0.000969	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SNRPE—melanoma	0.000303	0.000969	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—melanoma	0.000299	0.000954	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—melanoma	0.000295	0.000941	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000294	0.000938	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000294	0.000938	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—melanoma	0.000291	0.000929	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—melanoma	0.000288	0.00092	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—CDKN2B—melanoma	0.000288	0.00092	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000288	0.000919	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000287	0.000917	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—melanoma	0.000287	0.000917	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CTNNB1—melanoma	0.000286	0.000914	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—melanoma	0.000286	0.000914	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—VDR—melanoma	0.000281	0.000897	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—melanoma	0.000281	0.000897	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.00028	0.000895	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CDKN1A—melanoma	0.00028	0.000893	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—melanoma	0.00028	0.000892	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000278	0.000886	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLCB4—melanoma	0.000277	0.000883	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—melanoma	0.000275	0.000879	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000272	0.000867	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—melanoma	0.000271	0.000866	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000271	0.000865	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000271	0.000864	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000269	0.000859	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000268	0.000857	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MAPK1—melanoma	0.000265	0.000847	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EGFR—melanoma	0.000265	0.000847	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC6A11—melanoma	0.00026	0.00083	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIP4K2A—melanoma	0.00026	0.00083	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—melanoma	0.000257	0.00082	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—melanoma	0.000254	0.00081	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTAP—melanoma	0.000253	0.000808	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—melanoma	0.000252	0.000805	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—KRAS—melanoma	0.000251	0.0008	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—melanoma	0.00025	0.000797	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000248	0.00079	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000247	0.000789	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—melanoma	0.000246	0.000786	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000244	0.00078	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NFKB1—melanoma	0.00024	0.000767	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NPPA—melanoma	0.000237	0.000758	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.000235	0.00075	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPS3—melanoma	0.000234	0.000747	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—melanoma	0.000233	0.000745	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—melanoma	0.000233	0.000743	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000231	0.000738	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SKI—melanoma	0.00023	0.000735	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SNRPE—melanoma	0.00023	0.000735	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—melanoma	0.000228	0.000729	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—melanoma	0.000228	0.000729	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LUM—melanoma	0.000226	0.00072	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PHGDH—melanoma	0.000226	0.00072	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000225	0.000718	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—melanoma	0.000223	0.000711	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HPSE—melanoma	0.000221	0.000706	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.00022	0.000702	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.00022	0.000702	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	0.000219	0.000698	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000218	0.000696	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CUBN—melanoma	0.000217	0.000693	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—melanoma	0.000216	0.00069	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—melanoma	0.000216	0.000689	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—VDR—melanoma	0.000213	0.00068	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SDHD—melanoma	0.00021	0.000669	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BSG—melanoma	0.00021	0.000669	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CSPG4—melanoma	0.00021	0.000669	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000209	0.000668	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000208	0.000663	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH1—melanoma	0.000208	0.000662	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GPAM—melanoma	0.000203	0.000648	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—melanoma	0.000199	0.000634	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—melanoma	0.000196	0.000625	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—melanoma	0.000192	0.000612	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000191	0.000609	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000188	0.000601	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	0.000187	0.000596	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000185	0.000589	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NPPA—melanoma	0.00018	0.000575	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—melanoma	0.000174	0.000557	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HDAC2—melanoma	0.000174	0.000554	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLA2G6—melanoma	0.000173	0.000551	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000162	0.000517	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	0.000157	0.000503	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000156	0.000498	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—VCAN—melanoma	0.000155	0.000495	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	0.000151	0.000481	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—melanoma	0.000149	0.000474	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000147	0.000469	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000142	0.000452	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—CDKN2B—melanoma	0.000139	0.000443	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—VDR—melanoma	0.000135	0.000432	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HDAC2—melanoma	0.000132	0.000421	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP17A1—melanoma	0.000131	0.000418	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000129	0.000412	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000127	0.000407	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PRKCA—melanoma	0.000125	0.000398	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ERCC2—melanoma	0.000124	0.000395	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GNA11—melanoma	0.000124	0.000394	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—FASN—melanoma	0.000121	0.000386	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC5A5—melanoma	0.000119	0.00038	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GNAQ—melanoma	0.000115	0.000367	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CD44—melanoma	0.000115	0.000367	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000112	0.000359	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—melanoma	0.000112	0.000356	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000111	0.000356	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1B1—melanoma	0.00011	0.000352	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CDKN2B—melanoma	0.000105	0.000336	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—VDR—melanoma	0.000103	0.000328	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH1—melanoma	9.99e-05	0.000319	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.72e-05	0.00031	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PRKCA—melanoma	9.46e-05	0.000302	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—melanoma	9.43e-05	0.000301	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ERCC2—melanoma	9.39e-05	0.0003	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCB1—melanoma	9.07e-05	0.00029	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—melanoma	8.47e-05	0.00027	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PRKCA—melanoma	8.35e-05	0.000266	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ERCC2—melanoma	8.28e-05	0.000264	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH1—melanoma	7.58e-05	0.000242	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—melanoma	7.15e-05	0.000228	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.86e-05	0.000219	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CG—melanoma	6.54e-05	0.000209	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—melanoma	6.31e-05	0.000201	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CD—melanoma	5.75e-05	0.000183	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—melanoma	5.67e-05	0.000181	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MAPK3—melanoma	5.53e-05	0.000176	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—melanoma	5.38e-05	0.000172	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CB—melanoma	5.01e-05	0.00016	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—melanoma	4.96e-05	0.000158	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTEN—melanoma	4.33e-05	0.000138	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MAPK3—melanoma	4.19e-05	0.000134	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—melanoma	4.08e-05	0.00013	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—melanoma	3.73e-05	0.000119	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—melanoma	3.05e-05	9.75e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—melanoma	2.83e-05	9.03e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—melanoma	2.49e-05	7.96e-05	CbGpPWpGaD
